Order Your 5mg Mounjaro While Stock Available
5mg Mounjaro Available Now - No Waiting Lists
EverydayMeds maintains consistent stock of 5mg Mounjaro pens when other UK suppliers face shortages. Our established supply chain ensures you can order your prescription-only tirzepatide injection today at £159.99 (first order with FIRST40) or £174.99 for returning customers. Complete your clinical assessment and secure your pen before stock levels change.
All Mounjaro Doses Currently In Stock
Beyond 5mg pens, we stock the complete Mounjaro range: 2.5mg starter dose (£129.99 first order), 7.5mg (£209.99 first order), 10mg (£229.99 first order), 12.5mg (£259.99 first order), and 15mg maintenance dose (£278.99 first order). Consider our Progress Duo bundle (5mg + 7.5mg) at £369.99 for first orders - perfect for dose escalation without separate purchases.
Fast UK Approval Process
Our GPhC-registered pharmacy processes Mounjaro prescriptions efficiently. Standard approval takes 3 working days, or upgrade to express 24-hour approval to receive your 5mg pen faster. Once approved, your tirzepatide injection ships immediately with tracked delivery. No lengthy waits or uncertain timelines.
Reliable Supply Chain Advantage
While other pharmacies struggle with Mounjaro availability, EverydayMeds invested in robust supplier relationships ensuring consistent stock. Our customers avoid treatment interruptions that can affect progress. The 5mg dose often experiences high demand as patients escalate from 2.5mg, but we maintain adequate inventory levels.
Bundle Options for Better Value
Maximize savings with our in-stock bundles. The Intro Trio (2.5mg, 5mg, 7.5mg) costs £534.99 for first orders - £40 less than individual purchases. The Progress Trio (5mg, 7.5mg, 10mg) at £634.99 first order provides excellent value for ongoing treatment. All bundles ship together from current stock.
Prescription-Only Medicine Compliance
Mounjaro 5mg requires valid prescription following clinical assessment. Our qualified prescribers evaluate your suitability for tirzepatide treatment, ensuring safe usage alongside reduced-calorie diet and increased physical activity. This prescription-only approach maintains treatment safety while providing reliable UK access.
